62 related articles for article (PubMed ID: 18424416)
21. Heparanase gene haplotype (CGC) is associated with stage of disease in patients with ovarian carcinoma.
Ralph S; Brenchley PE; Summers A; Rosa DD; Swindell R; Jayson GC
Cancer Sci; 2007 Jun; 98(6):844-9. PubMed ID: 17419711
[TBL] [Abstract][Full Text] [Related]
22. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer.
Notaridou M; Quaye L; Dafou D; Jones C; Song H; Høgdall E; Kjaer SK; Christensen L; Høgdall C; Blaakaer J; McGuire V; Wu AH; Van Den Berg DJ; Pike MC; Gentry-Maharaj A; Wozniak E; Sher T; Jacobs IJ; Tyrer J; Schildkraut JM; Moorman PG; Iversen ES; Jakubowska A; Mędrek K; Lubiński J; Ness RB; Moysich KB; Lurie G; Wilkens LR; Carney ME; Wang-Gohrke S; Doherty JA; Rossing MA; Beckmann MW; Thiel FC; Ekici AB; Chen X; Beesley J; ; Gronwald J; Fasching PA; Chang-Claude J; Goodman MT; Chenevix-Trench G; Berchuck A; Pearce CL; Whittemore AS; Menon U; Pharoah PD; Gayther SA; Ramus SJ;
Int J Cancer; 2011 May; 128(9):2063-74. PubMed ID: 20635389
[TBL] [Abstract][Full Text] [Related]
23. Association of Four Interleukin-8 Polymorphisms (-251 A>T, +781 C>T, +1633 C>T, +2767 A>T) with Ovarian Cancer Risk: Focus on Menopausal Status and Endometriosis-Related Subtypes.
Watrowski R; Schuster E; Hofstetter G; Fischer MB; Mahner S; Van Gorp T; Polterauer S; Zeillinger R; Obermayr E
Biomedicines; 2024 Jan; 12(2):. PubMed ID: 38397923
[TBL] [Abstract][Full Text] [Related]
24. The Contribution of Tissue Inhibitor of Metalloproteinase-2 Genotypes to Breast Cancer Risk in Taiwan.
Wang YC; He JL; Tsai CL; Tzeng HE; Chang WS; Pan SH; Chen LH; Su CH; Lin JC; Hung CC; Bau DT; Tsai CW
Life (Basel); 2023 Dec; 14(1):. PubMed ID: 38276258
[TBL] [Abstract][Full Text] [Related]
25. Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome.
White KL; Vierkant RA; Fogarty ZC; Charbonneau B; Block MS; Pharoah PD; Chenevix-Trench G; ; Rossing MA; Cramer DW; Pearce CL; Schildkraut JM; Menon U; Kjaer SK; Levine DA; Gronwald J; Culver HA; Whittemore AS; Karlan BY; Lambrechts D; Wentzensen N; Kupryjanczyk J; Chang-Claude J; Bandera EV; Hogdall E; Heitz F; Kaye SB; Fasching PA; Campbell I; Goodman MT; Pejovic T; Bean Y; Lurie G; Eccles D; Hein A; Beckmann MW; Ekici AB; Paul J; Brown R; Flanagan JM; Harter P; du Bois A; Schwaab I; Hogdall CK; Lundvall L; Olson SH; Orlow I; Paddock LE; Rudolph A; Eilber U; Dansonka-Mieszkowska A; Rzepecka IK; Ziolkowska-Seta I; Brinton L; Yang H; Garcia-Closas M; Despierre E; Lambrechts S; Vergote I; Walsh C; Lester J; Sieh W; McGuire V; Rothstein JH; Ziogas A; Lubinski J; Cybulski C; Menkiszak J; Jensen A; Gayther SA; Ramus SJ; Gentry-Maharaj A; Berchuck A; Wu AH; Pike MC; Van Denberg D; Terry KL; Vitonis AF; Doherty JA; Johnatty SE; Defazio A; Song H; Tyrer J; Sellers TA; Phelan CM; Kalli KR; Cunningham JM; Fridley BL; Goode EL
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):987-92. PubMed ID: 23513043
[TBL] [Abstract][Full Text] [Related]
26. Novel Associations between BRCA1 Variants C.181 T>G (Rs28897672) and Ovarian Crisk in Saudi Females.
Alyahri N; Abdi S; Khan W; Elrobh M; Addar MH; Babay ZA; Alanazi M; Aldaihan S; Shaik J; Arafah M; Parine NR; Warsy A
J Med Biochem; 2019 Mar; 38(1):13-21. PubMed ID: 30820179
[TBL] [Abstract][Full Text] [Related]
27. MMP-9 -1562 Promoter Polymorphism Associated with Gastric Cancer Risk in Females.
Lee TY; Yu CC; Wu CC; Chang CS; Lin JT; Wu MS; Chen HP; Wu CY
Hepatogastroenterology; 2013 Feb; 60(126):. PubMed ID: 23372116
[TBL] [Abstract][Full Text] [Related]
28. RIPK1 polymorphisms and expression levels: impact on genetic susceptibility and clinical outcome of epithelial ovarian cancer.
Wang X; Deng K; Tao J; Zou J; Du Y; Dai L
Cancer Cell Int; 2023 Nov; 23(1):290. PubMed ID: 37996860
[TBL] [Abstract][Full Text] [Related]
29. Matrix Metalloproteases 8 Polymorphism as Risk Factor for Rotator Cuff Tear.
Cavascan NN; Assunção JH; Godoy-Santos AL; Neto AAF; Godoy Dos Santos MCL
Arch Bone Jt Surg; 2023; 11(9):565-569. PubMed ID: 37868135
[TBL] [Abstract][Full Text] [Related]
30. Role of MMP-2 (-1306 C/T) Polymorphism in Pituitary Adenoma.
Glebauskiene B; Liutkeviciene R; Vilkeviciute A; Kriauciuniene L; Bernotas G; Tamasauskas A; Zaliuniene D
Scientifica (Cairo); 2016; 2016():2839697. PubMed ID: 27051552
[TBL] [Abstract][Full Text] [Related]
31. Association of Rs11615 (C>T) in the excision repair cross-complementing group 1 gene with ovarian but not gynecological cancer susceptibility: a meta-analysis.
Ma YJ; Feng SC; Hu SL; Zhuang SH; Fu GH
Asian Pac J Cancer Prev; 2014; 15(15):6071-4. PubMed ID: 25124575
[TBL] [Abstract][Full Text] [Related]
32. The association of taxane resistance genes with the clinical course of ovarian carcinoma.
Ehrlichova M; Mohelnikova-Duchonova B; Hrdy J; Brynychova V; Mrhalova M; Kodet R; Rob L; Pluta M; Gut I; Soucek P; Vaclavikova R
Genomics; 2013 Aug; 102(2):96-101. PubMed ID: 23542236
[TBL] [Abstract][Full Text] [Related]
33. Association of R156R single nucleotide polymorphism of the ERCC2 gene with the susceptibility to ovarian cancer.
Romanowicz H; Michalska MM; Samulak D; Malinowski J; Szaflik T; Bieńkiewicz J; Smolarz B
Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():36-40. PubMed ID: 27888704
[TBL] [Abstract][Full Text] [Related]
34. Association of promoter methylation of VGF and PGP9.5 with ovarian cancer progression.
Brait M; Maldonado L; Noordhuis MG; Begum S; Loyo M; Poeta ML; Barbosa A; Fazio VM; Angioli R; Rabitti C; Marchionni L; de Graeff P; van der Zee AG; Wisman GB; Sidransky D; Hoque MO
PLoS One; 2013; 8(9):e70878. PubMed ID: 24086249
[TBL] [Abstract][Full Text] [Related]
35. Association of overexpression of hexokinase II with chemoresistance in epithelial ovarian cancer.
Suh DH; Kim MA; Kim H; Kim MK; Kim HS; Chung HH; Kim YB; Song YS
Clin Exp Med; 2014 Aug; 14(3):345-53. PubMed ID: 23949336
[TBL] [Abstract][Full Text] [Related]
36. Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay.
Fukumoto M; Estensen RD; Sha L; Oakley GJ; Twiggs LB; Adcock LL; Carson LF; Roninson IB
Cancer Res; 1989 Apr; 49(7):1693-7. PubMed ID: 2647292
[TBL] [Abstract][Full Text] [Related]
37. Association of MGMT promoter methylation with tumorigenesis features in patients with ovarian cancer: A systematic meta-analysis.
Qiao B; Zhang Z; Li Y
Mol Genet Genomic Med; 2018 Jan; 6(1):69-76. PubMed ID: 29195029
[TBL] [Abstract][Full Text] [Related]
38. The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility.
Zhao Z; Zhang A; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Li J; Duan P
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29669843
[TBL] [Abstract][Full Text] [Related]
39. [Association of intracellular proteinase activities with the content of locomotor proteins in tissues of primary tumors and metastasis in ovarian cancer].
Kondakova IV; Iunusova NV; Spirina LV; Kolomiets LA; Villert AB
Bioorg Khim; 2014; 40(6):735-42. PubMed ID: 25895370
[TBL] [Abstract][Full Text] [Related]
40. A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer.
Vollan HK; Rueda OM; Chin SF; Curtis C; Turashvili G; Shah S; Lingjærde OC; Yuan Y; Ng CK; Dunning MJ; Dicks E; Provenzano E; Sammut S; McKinney S; Ellis IO; Pinder S; Purushotham A; Murphy LC; Kristensen VN; ; Brenton JD; Pharoah PD; Børresen-Dale AL; Aparicio S; Caldas C
Mol Oncol; 2015 Jan; 9(1):115-27. PubMed ID: 25169931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
